What cannabis users should know about anti-doping rules
[When treatment has anti-doping implications: therapeutic use exemptions in primary care].
AI Summary
Therapeutic use exemptions (TUEs) can allow athletes to use otherwise prohibited medicines when there is a justified medical need and anti-doping requirements are met. The article emphasizes that these rules matter beyond elite sport, because family physicians may treat athletes in organized competitions or people subject to testing. It highlights medicines such as systemic glucocorticoids, β2-agonists, beta-blockers, and diuretics as treatments that may require careful review of dose, route, timing, and clinical context.
The abstract also warns that cannabinoids and some cold medicines or decongestants can contribute to unexpected adverse analytical findings. For cannabis users who compete in tested sports, the practical message is to discuss cannabis and other substances openly with a physician, check official anti-doping resources, and avoid assuming that medical use automatically protects against a rule violation. This is a practical guidance article, not a clinical trial, and the abstract reports no quantitative results.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
Treatment records show a sharp rise in stimulant use in Oman, 2019–2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risks…
Barcelona survey links teen pornography use with cannabis use and other outcomes
Explore More Research
Stay informed about the latest cannabis science.